Form 8-K - Current report:
SEC Accession No. 0001213900-24-069031
Filing Date
2024-08-14
Accepted
2024-08-14 16:15:16
Documents
13
Period of Report
2024-08-13
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0211342-8k_enzobio.htm   iXBRL 8-K 22237
  Complete submission text file 0001213900-24-069031.txt   193035

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE enz-20240813.xsd EX-101.SCH 3000
3 XBRL LABEL FILE enz-20240813_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE enz-20240813_pre.xml EX-101.PRE 22350
15 EXTRACTED XBRL INSTANCE DOCUMENT ea0211342-8k_enzobio_htm.xml XML 3557
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Filer) CIK: 0000316253 (see all company filings)

EIN.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 001-09974 | Film No.: 241208009
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)